Genevation LTD is a biopharma company developing and manufacturing personalised cancer vaccines. Genevation LTD’s mission is to treat every patient diagnosed with cancer differently. They have partnered with University of Cambridge/Illumina and are at the preclinical stage.
Genevation will be developing personalised cancer therapy, which works by using information about a person’s cancer. They will then use this information to develop an mRNA vaccine which will either kill the cancer cells or inhibit the growth of the cancer cells. This mode of treatment is safe and non-toxic and will help the individual to survive and live a healthy life.

Meet CEO and Founder of Genevation, Dr Prasun Chakraborty, in our CEO Spotlight video below.